In Brassica self-incompatibility, the recognition of self/nonself pollen grains, is controlled by the S-locus, which encodes three highly polymorphic proteins: S-locus receptor kinase (SRK), S-locus protein 11 (SP11; also designated S-locus Cys-rich protein), and S-locus glycoprotein (SLG). SP11, located in the pollen coat, determines pollen S-haplotype specificity, whereas SRK, located on the plasma membrane of stigmatic papilla cells, determines stigmatic S-haplotype specificity. SLG shares significant sequence similarity with the extracellular domain of SRK and is abundant in the stigmatic cell wall, but its function is controversial. We previously showed that SP11 binds directly to its cognate SRK with high affinity (K d ¼ 0.7 nM) and induces its autophosphorylation. We also found that an SLG-like, 60-kD protein on the stigmatic membrane forms a high-affinity binding site for SP11. Here, we show that the 60-kD stigmatic membrane protein is a truncated form of SRK containing the extracellular domain, transmembrane domain, and part of the juxtamembrane domain. A transiently expressed, membrane-anchored form of SRK exhibits high-affinity binding to SP11, whereas the soluble SRK (eSRK) lacking the transmembrane domain exhibits no high-affinity binding, as is the case with SLG. The different binding affinities of the membrane-anchored SRK and soluble eSRK or SLG will be significant for the specific perception of SP11 by SRK.
INTRODUCTION
Many flowering plants have evolved systems of self-incompatibility (SI) to prevent self-fertilization and to promote outbreeding. In the case of the SI in Brassica, the recognition of self and nonself pollen at the stigmatic surface is genetically controlled by a multiallelic S-locus. The S-locus generally contains three highly polymorphic genes: S-locus protein 11 (SP11; or S-locus Cysrich protein [SCR] ), S-locus glycoprotein (SLG), and S-locus receptor kinase (SRK).
SP11 encodes a secreted form of a small basic protein that localizes to the pollen coat Iwano et al., 2003) . The function of SP11 as a determinant of pollen S-haplotype specificity was definitively shown using a transgenic approach and a pollination bioassay (Schopfer et al., 1999; Takayama et al., 2000 Takayama et al., , 2001 Shiba et al., 2001) . SRK encodes a membrane-spanning Ser/Thr receptor kinase that localizes to the plasma membrane of stigmatic papilla cells. Gain-of-function experiments clearly demonstrated that SRK is the sole determinant of stigma S-haplotype specificity (Takasaki et al., 2000; Silva et al., 2001) . SLG encodes a secreted glycoprotein that accumulates abundantly (;100-fold of SRK) in the stigmatic cell wall (Kandasamy et al., 1989; Kishi-Nishizawa et al., 1990) . Transgenic experiments demonstrated that SLG is not directly involved in determining the S-haplotype specificity of the stigma (Takasaki et al., 2000; Silva et al., 2001) . In one transgenic experiment, transgenic plants of Brassica rapa into which SLG 28 (SLG from the S 28 -haplotype) was cointroduced with SRK 28 (SRK from the S 28 -haplotype) exhibited an enhanced SI response against pollen from S 28 -haplotype plants, suggesting a supporting role for SLG in the SI response (Takasaki et al., 2000) . However, this enhancing role of SLG was not observed when SRK 910 and SLG 910 genes from the self-incompatible Brassica napus W1 line were cointroduced into the self-compatible B. napus cv Westar line (Silva et al., 2001) .
Recent biochemical studies have revealed that SP11 is a direct ligand for SRK. Our previous cross-linking experiments using 125 I-labeled S 8 -SP11 suggested that S 8 -SP11 bound directly to SRK 8 in the stigmatic microsomal membranes . Furthermore, in an in vitro phosphorylation assay, S 8 -SP11 induced the autophosphorylation of SRK 8 in an S-haplotype-specific manner. The induction of SRK autophosphorylation was also observed after self-pollination in vivo (Cabrillac et al., 2001) . Together, these data suggest that during self-pollination, SP11 localized in the pollen coat spreads to papilla cell plasma membranes and binds the cognate SRK, inducing its autophosphorylation. Therefore, the S-haplotypespecific SP11-SRK interaction and SRK activation are responsible for self-pollen recognition and the subsequent triggering of the signaling cascade that results in self-pollen rejection.
Our previous reports have also suggested that 125 I-labeled S 8 -SP11 binds directly not only to SRK 8 but also to a 60-kD protein that is predicted to be a component of a high-affinity (K d ¼ 0.7 nM) SP11 binding site Takayama and Isogai, 2003) . Immunoprecipitation experiments have suggested that the 60-kD protein is an SLG-like protein, most likely SLG 8 or an extracellular domain of SRK 8 (eSRK 8 ), which was shown to be produced by alternative splicing of SRK (Stein et al., 1991; Giranton et al., 1995; Suzuki et al., 2003) . Indeed, eSRK has been detected as a soluble protein in the S 3 -haplotype of Brassica oleracea (Giranton et al., 1995) . Because of the high sequence homology of eSRK with SLG of the same haplotype (75 to 99%) and the fact that many other SLG-like proteins (termed the S-multigene family) are expressed in the stigma (Suzuki et al., 1995) , the 60-kD protein has not yet been identified precisely.
Here, we report the purification and characterization of the S 8 -SP11 high-affinity binding site from stigmatic microsomal membranes. The purified S 8 -SP11 high-affinity binding site contained both SRK 8 and the 60-kD protein, as suggested by our previous cross-linking experiments. Extensive immunological and biochemical characterization revealed that the 60-kD protein is neither SLG 8 nor eSRK 8 but rather a truncated form of SRK 8 (here termed tSRK) containing the extracellular domain, the transmembrane domain, and part of the juxtamembrane domain of SRK 8 . Transient expression analyses using cultured plant cells suggested that tSRK 8 is produced by posttranslational processing of SRK 8 . Interestingly, although both the artificially expressed membrane-anchored form of SRK 8 (mSRK 8 ) and the integral form of SRK 8 bound to S 8 -SP11 with high affinity, the soluble form of SRK 8 (eSRK 8 ) exhibited no high-affinity binding to S 8 -SP11. The artificially dimerized form of eSRK 8 , however, has been shown to exhibit high-affinity binding, suggesting that the membrane anchorage is necessary for SRK to acquire the highaffinity dimeric configuration. Our findings resemble the interactions between mammalian receptor tyrosine kinases (RTKs) and their ligands, and we discuss the implications of our observations for SI signal transduction.
RESULTS

Affinity Purification of the SP11 High-Affinity Binding Site from Stigmatic Membranes
To identify the components of the SP11 high-affinity binding site on the stigmatic membrane, we performed affinity purification using a chemically synthesized, biotin-labeled S 8 -SP11 (biotin-S 8 -SP11). The stigma homogenate was incubated with biotin-S 8 -SP11 and then separated into soluble and microsomal membrane fractions by ultracentrifugation. After detergent solubilization of the microsomal membrane fraction with Triton X-100, biotin-S 8 -SP11 binding proteins were pulled down from each fraction with streptavidin-Sepharose. The S 8 -SP11 binding proteins were detected by immunoblotting with an SLG 8 antibody (Ab-SLG 8 -C1) after electrophoretic separation (SDS-PAGE).
Ab-SLG 8 -C1 is a polyclonal antibody raised against an SLG 8 C-terminal peptide and detects not only SLG but also SRK from both the S 8 -and S 9 -haplotypes ( Figure 1A) . Figure 1 shows the results of the affinity purification of SP11 binding proteins. The total stigma extract contains large amounts of Ab-SLG 8 -C1-reactive 50-to 60-kD proteins, which produced broad bands after applying the sample equivalent of only one stigma (''total'' lanes in Figure 1A) . A large percentage of these proteins is SLG, which is a soluble protein contained specifically in the stigma at a high concentration (;0.2% [w/w] of total protein). The extracellular domain of SRK 8 (eSRK 8 ), which is produced by alternative splicing, also must be present in this fraction, although the precise amount is unknown (Giranton et al., Figure 1 . Purification of the SP11 High-Affinity Binding Site from Collected Stigmas.
Stigma homogenates from B. rapa S 8 -and S 9 -homozygotes were incubated with biotin-S 8 -SP11 or biotin-S 9 -SP11 and separated into the soluble and microsomal membrane fractions. The microsomal fraction was detergent-solubilized with 1% Triton X-100. The biotin-SP11 binding proteins were precipitated from each fraction by streptavidin-Sepharose and separated by SDS-PAGE. Asterisks indicate the 60-kD protein bands.
(A) Immunoblot analysis of the biotin-S 8 -SP11 binding proteins from soluble (sol) and microsomal membrane (mm) fractions (equivalent to ;1000 stigmas) using an anti-SLG 8 -C1 polyclonal antibody (Ab-SLG 8 -C1). Total stigma extracts (equivalent to one stigma; two left lanes) and the purified SLG (100 fmol; two right lanes) were also analyzed as controls.
(B) Immunoblot analysis of the biotin-S 9 -SP11 binding proteins (S 9 -SP11) and the biotin binding proteins (biotin; control) from the microsomal membrane fractions of S 9 -homozygotes. The proteins were detected using Ab-SLG 8 -C1. Purified SLG 9 (1 pmol) was analyzed as a control.
1995; Suzuki et al., 1996) . There are many other SLG-like proteins (termed the S-multigene family) also expressed in the stigma (Suzuki et al., 1995 (Suzuki et al., , 1997 Kai et al., 2001 ). However, these soluble proteins exhibit little to no S 8 -SP11 binding activity, and the affinity-bound fraction showed narrow bands even after applying a sample equivalent to 1000 stigmas, suggesting a <1:10,000 reduction by this single affinity purification step (''sol'' lanes in Figure 1A) .
By contrast, two Ab-SLG 8 -C1 antibody-reactive proteins were specifically affinity-purified from the microsomal membrane fraction of S 8 -haplotype plants (''mm'' lanes in Figure 1A) . These two proteins, with apparent molecular masses of 110 and 60 kD, were expected to correspond to two high-affinity receptor components detected previously in cross-linking experiments with 125 I-labeled S 8 -SP11 . In previous work, we suggested that the 110-kD protein was SRK 8 and that the 60-kD protein was SLG 8 or eSRK 8 . In this work, we reconfirmed, by immunoblotting with several peptide antibodies raised against SRK 8 , that the 110-kD protein is integral SRK 8 (see below).
What, then, is the 60-kD protein? Here, we found that the 60-kD protein recovered from the microsomal membrane fraction had a slightly larger molecular mass than SLG (;55 kD) purified from the soluble stigma fraction (''SLG'' lanes in Figure  1A) . In our previous cross-linking experiments, the 125 I-S 8 -SP11 To test whether the 60-kD protein is also present in other S-haplotypes, we repeated the pull-down experiment described above with stigmatic membranes from another S 9 -haplotype of B. rapa. In addition to the integral SRK 9 , biotin-labeled S 9 -SP11 precipitated a small amount of 60-kD protein that was larger than SLG 9 ( Figure 1B) . Thus, we consider the presence of the 60-kD protein in the stigmatic membrane to be a general feature, although its relative abundance differs between S-haplotypes.
Identification of the 60-kD Protein
To determine whether the 60-kD protein is an SLG-or SRKrelated protein, we immunoblotted with polyclonal antibodies that discriminate between SLG 8 and SRK 8 . Because the sequence similarity between the extracellular domains of SRK and SLG is relatively low in the S 8 -haplotype (84% amino acid identity), we obtained these antibodies by immunizing rabbits with distinct peptide fragments from SLG 8 and SRK 8 ( Figure 2C ).
Immunoblot analysis was performed using affinity-purified S 8 -SP11 binding proteins and purified SLG 8 as a control. The reactivities of the specific antibodies suggest that the 60-kD protein is not related to SLG 8 but rather to SRK 8 (Figure 2A To identify the 60-kD protein directly, we analyzed its proteolytic fragments using nanoscale liquid chromatographycoupled quadrupole time-of-flight tandem mass spectrometry. The affinity-purified 60-kD protein was separated by SDS-PAGE and excised after visualization by silver staining ( Figure 2B ). The protein bands collected from 40,000 stigmas were in-gel digested with trypsin, and the obtained tryptic peptides were subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Fourteen tryptic peptides were identified as fragments of the extracellular domain of SRK 8 from acquired MS/MS spectra based on the MASCOT and ProteinLynx 2.0 searching algorithms (Table 1) . Although 2 of these fragments were common to both SLG 8 and SRK 8 , the other 12 fragments were specific to SRK 8 ( Figure 2C ).
Among the 14 detected tryptic peptide fragments, the ion intensity of NQNVLMNTMTQSNK (N488 to K501), a juxtamembrane domain peptide from the 60-kD protein, was lower (approximately one-tenth) than that derived from the 110-kD protein (SRK 8 ). This observation suggests that the C terminus of the 60-kD protein is heterogeneous and that some extends beyond this juxtamembrane domain, but for the most part it terminates before the downstream end (K501) of this tryptic peptide. The fact that the adjacent upstream tryptic peptide fragment, AMA-TSIVNQQR (A477 to R487), was detected at similar intensities in both SRK 8 and the 60-kD protein suggests that the majority of the 60-kD protein terminates within the region spanning N488 to K501. In support of this idea, the peptide antibody Ab-SRK 8 -KD1, raised against the peptide M493 to Q503 ( Figure 2C ), strongly detected SRK 8 but only faintly stained the 60-kD protein ( Figure 2A ). The faint staining of the 60-kD protein band with the Ab-SRK 8 -KD1 antibody must be attributable to the fact that the proposed C termini of these forms lie within the N488 to K501 region, which largely overlaps the SRK 8 -KD1 epitope; therefore, some of the shorter species may lack the epitope required for recognition by the Ab-SRK 8 -KD1 antibody. The expected shorter C-terminal peptide fragment(s), however, was not detected by LC-MS/MS analyses. This is probably attributable to the low ionization efficiencies of peptides lacking the C-terminal Lys or Arg residue.
The presence of a membrane-anchored, truncated form of SRK was also suggested by protein gel blotting in the S 3 -haplotype of B. oleracea (Giranton et al., 1995) . The amount of the truncated form of SRK 3 was much lower than that of integral SRK 3 , similar to our observations with the S 9 -haplotype of B. rapa ( Figure 1B) . Thus, the occurrence of truncated forms seems to be a common feature of SRKs, although the relative abundance differs between S-haplotypes.
The Membrane-Anchored Form of Truncated SRK Is Sufficient for SP11 High-Affinity Binding
We investigated whether the membrane-anchored form of SRK 8 is active solely in S 8 -SP11 high-affinity binding. To test this notion, we transiently expressed three forms of SRK 8 in tobacco (Nicotiana tabacum) BY-2 cell protoplasts using a tomato mosaic virus expression system. These forms were eSRK 8 (the extracellular domain alone), mSRK 8 (the extracellular and transmembrane domains), and full-length SRK 8 . SLG 8 was also expressed in the same system as a control ( Figure 3A ).
In the BY-2 cell protoplasts, SLG 8 and eSRK 8 were expressed as soluble proteins and recovered from the culture medium, whereas SRK 8 and most of mSRK 8 were expressed as membrane-bound proteins and recovered from the microsomal membrane fractions. The binding affinities of these proteins for S 8 -SP11 were tested using in vitro pull-down assays similar to the purification of the high-affinity S 8 -SP11 binding site. The pulldown assays demonstrated that not only SRK 8 , but also mSRK 8 , has high-affinity S 8 -SP11 binding activity, whereas no binding activity was detected in the soluble forms of SLG 8 and eSRK 8 ( Figure 3B ). The binding ability of mSRK 8 indicated that the cytoplasmic kinase domain of SRK 8 is not essential for the binding of S 8 -SP11.
During the transient expression analyses, we noticed that the cells expressing full-length SRK 8 also produced the truncated form of SRK 8 in the microsomal membrane fraction and that this truncated SRK 8 was slightly larger than mSRK 8 ( Figure 3B ). Because we used the virus vector containing the full-length SRK 8 cDNA, this truncated SRK 8 must be posttranslationally generated from the integral SRK 8 . Because of this posttranslational processing, the pull-down assay using the cells expressing only full-length SRK 8 resulted in patterns similar (110-and 60-kD bands) to those from stigmas. These observations suggested the possibility that stigmatic tSRK 8 (the 60-kD protein) is also posttranslationally and probably proteolytically generated from SRK 8 .
Contrary to our previous predictions, the soluble form of eSRK 8 displayed no detectable binding to S 8 -SP11, as was the case with SLG 8 . To confirm this result, we repeated the pulldown assay in the presence of both full-length SRK 8 and eSRK 8 . S 8 -SP11 selectively bound to full-length SRK 8 and its processing product tSRK 8 , but no binding was detected with eSRK 8 ( Figure  3C ). These results strongly suggested that membrane anchorage is critical for the high-affinity binding of SRK to SP11.
Membrane-Anchored SLG Exhibits No High-Affinity Binding to SP11
SLG 8 in the stigma soluble fraction exhibited no high-affinity binding to S 8 -SP11. Previous interaction analyses using surface plasmon resonance also failed to detect an interaction between S 8 -SP11 and SLG 8 ). However, because SLG shares significant homology with the extracellular domain of cognate SRK, SLG might potentially interact with SP11 under certain circumstances. To test this notion, we transiently expressed a membrane-anchored form of SLG 8 (mSLG 8 ), a chimeric protein consisting of SLG 8 and the transmembrane domain of SRK 8 . Immunoblotting confirmed that the majority of mSLG 8 and mSRK 8 was expressed as similarly sized microsomal membrane proteins, although small portions shed from the membrane were also detected in the soluble fraction of the cell extract ( Figure 4A ). The microsomal membrane fraction was subjected to the biotin-S 8 -SP11 pull-down assay. Figure 4B illustrates that mSLG 8 , in contrast with mSRK 8 , does not acquire high-affinity binding activity with S 8 -SP11, despite its anchorage in the plasma membrane.
Membrane Anchorage Is Necessary for Truncated SRK to Establish High-Affinity Binding to SP11
To better understand how the membrane anchorage of SRK facilitates high-affinity SP11 binding, we performed pull-down assays before and after solubilizing the stigmatic microsomal membranes. Before solubilization of the microsomal membranes with Triton X-100, both full-length SRK 8 and the truncated tSRK 8 exhibited high-affinity binding to S 8 -SP11 ( Figure 5 ). However, most of the high-affinity binding activity of tSRK 8 was lost after solubilization of the microsomal membrane. This observation suggested that the membrane anchorage is necessary for tSRK to establish high-affinity binding with S 8 -SP11. Nevertheless, the integral SRK 8 , at least in part, maintained its high-affinity binding activity even after solubilization of the microsomal membrane.
A Dimeric Form of eSRK Exhibits High-Affinity Binding to SP11
Previous cross-linking experiments have shown that SRK exists as a dimer on the stigmatic membrane of nonpollinated flowers (Giranton et al., 2000) . Velocity sedimentation analytical ultracentrifugation also suggested that the integral form of stigmatic SRK exists as a dimer even after detergent solubilization of the plasma membrane, whereas SLG and eSRK exist primarily as monomers (Giranton et al., 2000) . These data suggested that the high-affinity SP11 binding activity of SRK can be attributed to its dimeric condition. To test this hypothesis, we made a construct for the eSRK 8 -HLH-ZIP fusion protein that spontaneously dimerizes via an introduced C-terminal helix-loop-helix zipper (HLH-ZIP) domain from sterol-regulatory element binding protein 2 (Nagoshi and Yoneda, 2001 ). The eSRK 8 -HLH-ZIP fusion protein transiently expressed in BY-2 cells exhibited high-affinity binding to S 8 -SP11 ( Figure 6A ). To confirm this result in another S-haplotype, we expressed both eSRK 9 and eSRK 9 -HLH-ZIP proteins in the stably transformed BY-2 cells. In contrast with eSRK 9 , which showed no high-affinity binding, the eSRK 9 -HLH-ZIP fusion protein exhibited high-affinity binding to S 9 -SP11 ( Figure 6B ). Furthermore, when these binding experiments were conducted in the presence of stigmatic membranes from S 9 -homozygotes, the eSRK 9 -HLH-ZIP fusion protein, but not eSRK 9 , exhibited high-affinity binding comparable to that of integral SRK 9 on the stigmatic membrane ( Figure 6C ). These results suggest that dimerization can be a crucial event preceding the acquisition of high-affinity binding of SRK to SP11.
DISCUSSION
In this study, we purified the high-affinity SP11 binding site on the stigmatic membrane using biotin-tagged SP11. The high-affinity binding site was suggested to exist at only 180 fmol/mg stigmatic microsomal membrane proteins, corresponding to ;1 fmol/ stigma Takayama and Isogai, 2003) . The purified high-affinity binding site consisted of two proteins of 110 and 60 kD, as suggested previously by cross-linking experiment using radiolabeled SP11. Thorough immunochemical and LC-MS/MS analyses revealed that the 110-kD protein is integral SRK and that the 60-kD protein is neither SLG nor eSRK but rather the membrane-anchored form of tSRK. The tSRK is ;5 kD larger than SLG or eSRK, which we had not noticed in our previous study ) because we only detected the protein band after cross-linking with 125 I-labeled-SP11 and thus could not determine its original molecular size. Another unexpected finding was that in contrast to the integral and membrane-anchored forms of SRK, which exhibited highaffinity binding to SP11, the soluble form of SRK (eSRK) exhibited no high-affinity binding. This finding suggests that the membrane anchorage is necessary for SRK to create a high-affinity binding site for SP11. This conclusion was further supported by the observation that the membrane-anchored form of tSRK lost its high-affinity binding activity after solubilizing the microsomal membrane with detergent, whereas the integral form of SRK retained its binding activity to a certain extent (see below for further discussion).
The pull-down method used in this study was designed to detect only high-affinity, stabilized interactions between SP11 and its binding site. We used nanomolar levels of biotin-SP11 to (B) SLG 8 , eSRK 8 , mSRK 8 , and full-length SRK 8 were transiently expressed in tobacco BY-2 cell protoplasts. Biotin-S 8 -SP11 (þ) or biotin (À) was incubated with the cell extracts, and the interacting proteins were recovered using streptavidin-Sepharose (see Methods). The recovered proteins (pull-down) and the BY-2 cell extracts before precipitation (input) were separated by SDS-PAGE and probed by immunoblotting with the antibody Ab-SLG 8 -C1. (C) Pull-down assays in the presence of both full-length SRK 8 and eSRK 8 . The microsomal membrane fraction of BY-2 cells expressing SRK 8 was incubated with biotin-S 8 -SP11 (þ) or biotin (À) in the presence of large quantities of soluble eSRK 8 . Interacting proteins (pull-down) and the proteins before precipitation (input) were immunoblotted with the antibody Ab-SLG 8 -C1. detect the interaction, and no chemical cross-linkers were used before membrane solubilization, during ultracentrifugation, or in the subsequent high-salt washes. Most mammalian RTKs, such as epidermal growth factor receptor and fibroblast growth factor receptor, are thought to exist in an autoinhibited state before stimulation by their ligands (Schlessinger, 2003) . These autoinhibited RTKs exist in monomeric or inactive dimeric states and are in equilibrium with the small population of unoccupied receptors that are in an active dimeric configuration compatible with trans-autophosphorylation. The latter bind to ligands with high affinity, which shifts the equilibrium toward the stabilized dimeric active configuration, resulting in autophosphorylation (in trans) of Tyr residues in the catalytic core and kinase activation (Jiang and Hunter, 1999; Schlessinger, 2000) . We have shown previously ) that SP11 interacts with its cognate SRK on the stigmatic membrane in an S-haplotypespecific manner. The SP11-interacting SRK is recovered from the plasma membrane in its activated form, which exhibits increased autophosphorylating activity. These results strongly suggest that SP11 also induces SRK dimerization or some rearrangement of a preformed SRK dimer and that the conformational change stabilizes the SP11-SRK interaction and the subsequent SRK activation.
In the context of this model, the membrane anchorage is necessary for SRK to maintain its configuration in the equilibrium state between the inactive monomeric or dimeric low-affinity form(s) and the dimeric active high-affinity form. Formation of the active dimer must be supported by the cell membrane, which restricts receptor diffusion in two dimensions (Tzahar et al., 1997) . These arguments are strongly supported by the observation that the inactive soluble form of eSRK also acquired highaffinity binding activity by artificial dimerization via a C-terminal HLH-ZIP domain. Similar results were reported in mammalian transmembrane receptors, in which the soluble forms of extracellular domains often exhibited ligand binding affinities one order of magnitude lower than their integral forms (Nagao et al., 1992; Yet and Jones, 1993; Zhou et al., 1993) . Structural studies have suggested that the soluble forms exist as inactive monomers whose dimerization is autoinhibited by intramolecular interactions (Schlessinger, 2002) . It is also suggested that these inactive soluble receptors acquire high-affinity configurations by increasing their local densities, such as by increasing receptor concentrations, by chemically cross-linking monomeric receptors, or by providing membrane anchorage to the soluble receptors (Bö ni-Schnetzler and Pilch, 1987; Hurwitz et al., 1991; Zhou et al., 1993) .
The oligomeric status of SRK has actually been observed in planta by cross-linking and velocity sedimentation experiments (Giranton et al., 2000) . These data strongly suggested that SRK molecules do indeed exist as dimers or oligomers on nonpollinated stigmatic membranes, whereas SLG and eSRK exist primarily as monomers. It was also suggested that the integral form of stigmatic SRK retained its oligomeric status even after membrane solubilization by Triton X-100 but was resolved to a monomer after SDS treatment in the absence of a reducing agent (Giranton et al., 2000) . These results are consistent with our observation that the integral form of SRK, at least in part, retained high-affinity binding activity for SP11 even after membrane solubilization, whereas most solubilized tSRK lost its high-affinity binding activity. These data suggest that most SRK on the nonpollinated stigmatic membrane spontaneously and noncovalently associates to form inactive dimers, which must still be an autoinhibited configuration. The kinase domain of SRK contributes to stabilizing the dimeric form, although the precise molecular mechanisms are unknown. The SP11 binding on these preformed dimers is supposed to induce specific, intersubunit conformational changes within a dimer, leading to a stabilized dimeric configuration and full activation, as was reported for RTKs (Jiang and Hunter, 1999) . Despite the central importance of the receptor kinases in plant signal transduction, most of which are Ser/Thr kinases, unlike mammalian RTKs, their ligand perception and their activation mechanisms are poorly understood at the molecular level. In this study, we present an example of a plant receptor-like kinase being activated through a homodimerization process.
The actual SP11 binding affinities of eSRK and SLG remain unclear. We assumed that eSRK had a low binding affinity for SP11, although it could not be measured using our current assay system. Nasrallah's group demonstrated S-haplotypespecific interactions between eSRK 6 (or eSRK 13 ) and the cognate SCR/SP11s using recombinant proteins (Kachroo et al., 2001; Chookajorn et al., 2004) . They measured interactions by ELISA or pull-down assay using eSRKs anchored to plates or resin. Although exact values are unknown because most of the binding data were not described by K d but rather by binding maximum values, the binding affinities were assumed to be low based on the experimental SP11 concentrations. In addition, because they immobilized huge amounts of eSRK (0.5 to 0.75 mg) on wells or in the resin, the local densities of eSRKs were expected to be rather high-possibly high enough for the spontaneous oligomerization of the eSRKs. In our experiments, in which SP11 and eSRK were mixed in solution at levels <50 nM, no such interactions were detected. We show here that the artificially dimerized form of eSRK exhibited high-affinity binding to SP11 in solution. The use of this form of eSRK would help in investigations of the structural basis of SP11-SRK interactions (e.g., to assess the residues that are important for the interaction and to map sequences that determine recognition specificity between different S-haplotypes). Our findings also have potential implications for future studies on other plant receptor kinases, including the design of experimental strategies for ligand searches for the orphan receptor kinases. Affinity purification of the ligand using the extracellular domains of receptor kinases is expected to be unsuccessful in experiments with SRK-like receptor kinases.
In stigmatic papilla cells, SLG accumulates abundantly in the cell wall, where eSRK is also present (Giranton et al., 1995) . The quantity of SRK on the plasma membrane is approximately two orders of magnitude lower than that of these soluble proteins (Giranton et al., 1995; Kemp and Doughty, 2003) . When the pollen grain lands on a papilla cell, SP11 from the pollen coat must pass through the SLG/eSRK-rich cell wall space to reach SRK on the plasma membrane to initiate SI signaling. Thus, it seems reasonable that SLG/eSRK would bind SP11 with lower affinity. What, then, are the biological functions of SLG and eSRK? Why are the SLG alleles distributed across so many Brassica S-haplotypes? Why are the splice site and the in-frame stop codon at the 59 end of the first intron used to produce eSRK so well conserved in alleles of SRK (Giranton et al., 1995; Suzuki et al., 1996) ? Plants are known to produce many soluble receptorlike proteins that are highly similar in sequence to the extracellular domains of their corresponding receptor kinases (Torii, 2000) . These truncated forms are produced either from the same (A) The HLH-ZIP-fused extracellular domain of eSRK 8 (eSRK 8 -HLH-ZIP) was incubated with biotin-S 8 -SP11 (þ) or biotin (À). Interacting proteins (pull-down) and the proteins before precipitation (input) were analyzed by immunoblotting with the antibody Ab-SLG 8 -C1. (B) The binding of eSRK 9 and eSRK 9 -HLH-ZIP to biotin-S 9 -SP11 was analyzed as in (A). (C) The stigmatic microsomal membrane fraction of S 9 -homozygotes was incubated with biotin-S 9 -SP11 in the presence of soluble eSRK 9 or eSRK 9 -HLH-ZIP. Binding was analyzed as in (A).
gene by alternative splicing, as in the case of eSRK, or from different genes, as in the case of SLG. In either case, the physiological significance of the soluble forms of receptor kinases is virtually unknown. One emerging hypothesis suggests that these soluble receptor-like proteins form heterodimers with corresponding receptor kinases in the presence of ligands, triggering signaling cascades within the cell. However, our previous prediction that SLG and/or eSRK would be involved in SP11 perception together with SRK was not borne out by this study. The biological functions of SLG and eSRK should be reexamined in future studies.
We revealed that the 60-kD stigma protein is a membraneanchored form of tSRK that contains the extracellular domain, the transmembrane domain, and the short intracellular (juxtamembrane) region but that lacks the kinase domain. In this study, we demonstrated the presence of tSRKs in two S-haplotypes (S 8 -and S 9 -haplotypes) of B. rapa. The presence of tSRK was also suggested in the S 3 -haplotype of B. oleracea (Giranton et al., 1995) , suggesting that the occurrence of the tSRK might be a general feature of SRKs. Because the corresponding protein was also produced in tobacco cells transformed with SRK cDNA, tSRK must be posttranslationally produced from integral SRK, probably by a protease that is present in both Brassica and tobacco cells. A similar proteolytic cleavage has been reported in XA21, a rice (Oryza sativa) receptor kinase that confers resistance against the phytopathogenic bacterium Xanthomonas oryzae pv oryzae (Xu et al., 2006) . Although the precise cleavage site and the protease involved have not been determined, XA21 was shown to be proteolytically cleaved within the intracellular juxtamembrane domain by developmentally controlled proteolytic activity.
It remains unknown whether tSRK has a special function in SI signaling. In mammalian RTKs, certain truncated forms lacking the kinase domain play critical roles in signal transduction. For example, certain truncated neurotrophin receptor kinases of TrkB and TrkC have been shown to form dimers with, and thereby inhibit the activation of, the integral forms of these receptors (Biffo et al., 1995) . On the other hand, one of these truncated Trks, TrkB-T1, has a specialized positive function that activates calcium release from intracellular stores by ligand binding in astroglial cells (Rose et al., 2003) . To determine the physiological function of tSRK, we must design experiments in which the production of tSRK in the papilla cell can be artificially regulated. Determining the precise C-terminal tSRK cleavage site and identifying the protease involved in the cleavage will shed light on the molecular function of tSRK.
METHODS
Synthesis of Biotin-Labeled SP11
S 8 -SP11 and S 9 -SP11 were chemically synthesized by the Peptide Institute as described previously . Biotin-S 8 -SP11 was chemically synthesized by assembling the biotinylated pentapeptide (biotinyl-QELEA) at the N terminus of S 8 -SP11. Biotin-S 9 -SP11 was prepared by chemically labeling S 9 -SP11 (17 nmol) with biotin-(AC 5 ) 2 sulfoOSu (20 nmol; Dojin) at room temperature for 90 min. Biotin-labeled SP11s were purified to a single peak by reverse-phase HPLC.
Purification of the High-Affinity SP11 Binding Site from Stigma Stigmas were collected from S 8 -and S 9 -homozygotes of Brassica rapa on the day of anthesis and stored at À808C until use. The stigmas were homogenized in binding buffer (50 mM HEPES-KOH, pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 2 mM MnCl 2 , 10 mM NaF, 10 mM b-glycerophosphate, 0.005% Triton X-100, 1 mM DTT, and EDTA-free protease inhibitor cocktail [Roche] ). The homogenates were treated with 10 nM biotin-S 8 -SP11, biotin-S 9 -SP11, or biotin (control) for 60 min on ice and then separated into supernatants and microsomal membranes by ultracentrifugation (120,000g for 60 min at 48C). The microsomal membranes were solubilized with 1% Triton X-100, and the extracts were collected by ultracentrifugation at 120,000g for 30 min at 48C. The biotin-S 8 -SP11 binding proteins were recovered by streptavidin-Sepharose (Amersham Biosciences). After washing the resin three times with binding buffer and three times with wash buffer (50 mM HEPES-KOH, pH 7.4, 300 mM NaCl, 5 mM MgCl 2 , 2 mM MnCl 2 , 10 mM NaF, 10 mM b-glycerophosphate, 0.005% Triton X-100, and 1 mM DTT), the biotin-SP11-bound proteins were eluted by the addition of SDS-PAGE sample buffer (50 mM Tris-HCl, pH 6.8, 10% [v/v] glycerol, 2% [w/v] lithium dodecyl sulfate, and 10 mM DTT) and boiling. The eluted proteins were separated by SDS-PAGE (4 to 12% acrylamide gel) and visualized using a Silver Staining II kit (Wako).
Antibody Production and Immunoblotting
Polyclonal antibodies against SRK 8 and SLG 8 were generated in rabbits by immunization with the keyhole limpet hemocyanin-conjugated peptides (SRK 8 -M1, CTGELEDMRNYAEGGQD; SRK 8 -KD1, CMNTMTQSNKRQ; SLG 8 -M1, CTGELEDIRTYFADGQD; SLG 8 -C1, CADGQDLYVRLAAADLV). The IgG fractions of the obtained antisera were affinity-purified using the peptide-conjugated resin. For immunoblotting, the proteins were separated by SDS-PAGE (4 to 12% acrylamide) and transferred to polyvinylidene difluoride membranes. Blots were incubated with the affinity-purified antibodies and then developed with horseradish peroxidase-labeled antirabbit IgG and the ECL Plus chemiluminescence detection system (Amersham).
Identification of the SP11 Binding Protein by LC-MS/MS Analysis
The affinity-purified stigmatic proteins were separated by SDS-PAGE (4 to 12% acrylamide) and stained by MS-compatible silver staining (Shevchenko et al., 1996) . The protein band (60-kD range) was manually excised and subjected to in-gel trypsin digestion (Shevchenko et al., 1996; Wilm and Mann, 1996) . The extracted tryptic peptides were concentrated by vacuum centrifugation and analyzed by LC-MS/MS. LC-MS/MS analyses were performed on a nanoESI-Qq-TOF Ultima mass spectrometer (Waters-Micromass) interfaced on-line with a capillary HPLC system (Waters-Micromass Modular CapLC) using a reversephase trapping column (PepMap microcolumn containing 5 mm of C18 100-Å PepMap, 0.3 mm inner diameter 3 1 mm; LC Packings) and a reverse-phase capillary column (NanoEase capillary column containing Atlantis dC18 3 mm 100-Å , 75 mm inner diameter 3 150 mm; Waters). The top two ions in each survey scan were subjected to automatic MS/MS fragmentation analysis in low-energy collision-induced dissociation. The acquired MS/MS spectra were searched against the National Center for Biotechnology Information database using the Mascot 2.0 searching algorithm (Matrix Science) or ProteinLynx Global Server 2.0 software (Waters).
Transient Expression of SRK/SLG-Related Proteins in Tobacco BY-2 Cell Protoplasts
The integral forms of SRK 8 , SLG 8 , and their derivatives were produced in the protoplasts of tobacco (Nicotiana tabacum) BY-2 suspension cultured cells using a tomato mosaic tobamovirus system (Hori and Watanabe, 2003) . The protoplasts of BY-2 cells were prepared as described (Watanabe et al., 1987) . The cDNA fragments corresponding to eSRK 8 (amino acids 1 to 443), mSRK 8 (amino acids 1 to 468), and full-length SRK 8 (amino acids 1 to 858) were amplified from an SRK 8 cDNA clone by PCR and cloned into the tomato mosaic tobamovirus-derived vector TogJ, which is a modified TocJ vector (Hori and Watanabe, 2003) . The chimeric mSLG 8 construct was created by combining the full-length SLG 8 coding region and the SRK 8 transmembrane domain (amino acids 436 to 468) coding region. The HLH-ZIP fusion eSRK 8 (eSRK 8 -HLH-ZIP) was prepared by fusing the HLH-ZIP (amino acids 343 to 403) coding region of SREBP-2 (Nagoshi and Yoneda, 2001) in-frame to an eSRK 8 (amino acids 1 to 443) cDNA fragment. The combined fragments of mSLG 8 and eSRK 8 -HLH-ZIP were also cloned into TogJ. In vitro transcripts were produced using a T7 kit (Promega) and introduced into the protoplasts by electroporation. The protoplasts were harvested after culturing for 15 h at 288C and homogenized with a pestle in binding buffer. The homogenates were centrifuged for 1 h at 120,000g, and the supernatants were used as the soluble fraction. The pellets were resuspended in binding buffer and used as the microsomal fraction. Biotin-S 8 -SP11 (25 nM) was added to these fractions and incubated for 60 min on ice. The interacting proteins were recovered by streptavidin-Sepharose from the soluble fraction, and the microsomal fraction was solubilized with 1% Triton X-100.
Stable Expression of eSRK 9 and eSRK 9 -HLH-ZIP Proteins in BY-2 Cultured Cells
The extracellular domain of SRK 9 (eSRK 9 ) and the eSRK 9 -HLH-ZIP fusion protein were stably expressed in BY-2 suspension cultured cells. The cDNA fragment corresponding to eSRK 9 (amino acids 1 to 436) was amplified from the SRK 9 cDNA clone by PCR and fused with cDNA encoding the FLAG epitope tag. The HLH-ZIP fusion eSRK 9 (eSRK 9 -HLH-ZIP) was generated by sequentially annealing the eSRK 9 (amino acids 1 to 436) open reading frame, the HLH-ZIP domain (amino acids 343 to 403) coding sequence, and the FLAG epitope tag. For greater protein accumulation, the coding sequence of the C-terminal propeptide (amino acids 335 to 353) of horseradish peroxidase C1a was fused to the eSRK 9 -FLAG and the eSRK 9 -HLH-ZIP-FLAG constructs. The C-terminal propeptide is responsible for the protein sorting to vacuoles and is removed before or concomitant with production of the mature protein (Lerouge et al., 1998; Matsui et al., 2003) . The obtained constructs were subcloned into the binary vector pMSH1 under the control of the cauliflower mosaic virus 35S promoter and the 59 untranslated region of the tobacco alcohol dehydrogenase gene. These binary vectors were introduced into BY-2 tobacco cells by Agrobacterium tumefaciens-mediated transformation (Nakayama et al., 2000) . The transformed BY-2 cells were homogenized in extraction buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl 2 , 0.05% Tween 20, 1 mM DTT, and EDTA-free protease inhibitor cocktail [Roche]), and the recombinant proteins were purified from the supernatants using an anti-FLAG M2 affinity gel (Sigma-Aldrich). The recombinant proteins were eluted with 100 mg/mL FLAG peptide, dialyzed with binding buffer, and concentrated using Centricon YM30 concentrators (Pierce). These purified fusion proteins were incubated with biotin-S 9 -SP11 (25 nM) for 60 min on ice, and the interacting proteins were recovered by streptavidin-Sepharose. For binding analysis in the presence of stigmatic membranes from S 9 -homozygotes, the concentration of biotin-S 9 -SP11 was changed to 10 nM and incubated for 90 min on ice.
Accession Numbers
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